Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

OTCPK:TSPH
OTCPK:TSPHTransportation

Undervalued Penny Stocks To Watch In October 2025

As the U.S. stock market experiences gains amid trade news with China and a surge in oil futures, investors are keeping a close eye on emerging opportunities. Penny stocks, despite their somewhat outdated label, remain an intriguing area for those interested in smaller or newer companies that might offer untapped potential. These stocks can provide growth opportunities at lower price points when supported by strong financials and sound fundamentals.
CNSX:HBFG
CNSX:HBFGHealthcare Services

The Bull Case For Happy Belly Food Group (CNSX:HBFG) Could Change Following Heal Wellness's Eaton Centre Debut

Happy Belly Food Group recently announced that Heal Wellness has signed a franchise agreement and secured a prime location at Toronto's Eaton Centre, one of Canada’s busiest retail destinations. This move marks Heal Wellness’s first presence in a high-traffic, flagship venue and supports rapid expansion, with over 168 new locations in development and 626 franchise commitments across Happy Belly’s portfolio. We'll explore how entering the Eaton Centre reflects on Happy Belly Food Group's...
TSXV:WEB
TSXV:WEBRenewable Energy

TSX Penny Stocks To Consider In October 2025

As we approach the end of 2025, the Canadian market is navigating a landscape marked by economic uncertainties such as trade tensions and emerging credit concerns. Despite these challenges, favorable factors like anticipated interest rate cuts and positive corporate earnings growth suggest a resilient outlook for investors. In this context, penny stocks—often representing smaller or newer companies—continue to offer intriguing opportunities for those seeking growth at lower price points. By...
TSE:5105
TSE:5105Auto Components

Toyo Tire (TSE:5105): Valuation Spotlight After CEO Confidence and Share Buyback Plans

Toyo Tire (TSE:5105) shares are getting attention after the CEO projected the company will surpass profit forecasts this year, citing ongoing strong US demand and a planned share buyback program. See our latest analysis for Toyo Tire. After a bumpy start to the year, Toyo Tire’s momentum has shifted into high gear, with the latest leadership confidence and share buyback plans fueling a powerful rally. The one-year total shareholder return now stands at an impressive 107%, and strong demand...
NYSEAM:ARMP
NYSEAM:ARMPBiotechs

A Look at Armata Pharmaceuticals’s Valuation After Positive Phase 2a Bacteriophage Trial Results (ARMP)

Armata Pharmaceuticals (ARMP) just reported encouraging Phase 2a trial results for its experimental IV bacteriophage therapy, AP-SA02, targeting complicated Staphylococcus aureus bacteremia. The data was revealed during a presentation at IDWeek 2025. See our latest analysis for Armata Pharmaceuticals. News of Armata’s clinical breakthrough sent its share price surging 103% in a single day, fueling a remarkable 261% gain for investors year-to-date. Recent momentum has reversed previous years...
NYSE:FPI
NYSE:FPISpecialized REITs

Insider Buying Highlights 3 Undervalued Small Caps Across Regions

Amidst a backdrop of U.S.-China trade tensions and ongoing government shutdown, major stock indexes have ended lower as investors digest recent earnings reports. In this challenging market environment, identifying promising small-cap stocks can be pivotal, especially those that show resilience and potential for growth despite broader economic pressures.
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

High Growth Tech Stocks in the US to Watch for October 2025

As the U.S. market grapples with a mix of earnings reports and renewed U.S.-China trade tensions, major indices like the Nasdaq, Dow Jones Industrial Average, and S&P 500 have recently faced downward pressure. In such a volatile environment, identifying high growth tech stocks requires careful consideration of their resilience to geopolitical issues and their ability to innovate amidst economic challenges.
ASX:PAR
ASX:PARBiotechs

Paradigm Biopharmaceuticals (ASX:PAR): Assessing Valuation as Investor Focus Builds Ahead of Ignite Summit Presentation

Paradigm Biopharmaceuticals (ASX:PAR) is drawing increased attention ahead of its scheduled presentation at the Ignite Investment Summit in Hong Kong, where the company’s founder and executive team will address investors. See our latest analysis for Paradigm Biopharmaceuticals. After a year defined by volatility, Paradigm's share price has rebounded sharply with a 56% gain over the past month. This signals fresh momentum ahead of its summit appearance. While the short-term rally is grabbing...